|
|
||||||||
Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, New York
Aware Electronics, Wilmington, Delaware
Correspondence: For correspondence or reprints contact: LS. Zuckier, MD, Department of Nuclear Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461.
ABSTRACT
In many countries, patients treated with therapeutic amounts of 131I are hospitalized because of radiation safety considerations. To determine when they can return home, radiation levels are intermittently monitored at bedside using a handheld Geiger-Müller (GM) counter, although this procedure can be cumbersome and inexact. Methods: We have developed and tested a remotely pollable system for continuous radiation monitoring of 131I therapy inpatients, using readily available hardware and standard telephone lines. The remote detector system, consisting of a palmtop IBM compatible personal computer, specialized software, PCMCIA modem and miniature serial port-based GM detector, is placed opposite the patient's bed at a fixed distance, and continuous 1-min acquisitions are started. Initially and at least twice daily, the remote palmtop is contacted by modem, and all interval data are uploaded onto the operator's base computer over the telephone line, including measurements taken with the patient in a predetermined standardized position. Continuous minute-to-minute data may be viewed in native form or can be imported into graphing and spreadsheet programs. Points acquired with the patient in standardized position are specially marked to highlight the constant geometry used. The ratio of initial counting rate to administered dose is used to estimate residual 131I body burden by proportionality. Display of data as a semilogarithmic plot facilitates extrapolation of the activity curves and prediction of the patient's earliest time of discharge. Results We have characterized the remote GM detector system to confirm accuracy, counting rate linearity and reliability of data transfer. We describe examples that illustrate the applicability and usefulness of this method for remote monitoring of inpatient 131I therapy levels. Conclusion: Monitoring patients with the described remotely pallable GM detector is an accurate and easy-to-implement technique that could conceivably lead to shortened hospital stays for 131I therapy inpatients. Continuous quantitative data obtained are useful for kinetic and dosimetric analyses, which may be applied to study other gamma-emitting radiopharmaceuticals as well. The flexibility of the technique may permit its use in the monitoring of therapy on an outpatient basis, where allowed.
Key Words: Geiger-Müller detector remote monitoring iodine-131 therapy
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |